EGFR and inflammatory breast carcinoma: In BRCA1 mutation carriers with IBC + DCIS, the correlation between the DCIS and IBC (Tables 2, 3) was highly significant for ER, PR, HER1, HER3 (Fig. 3), and C-MET (Fig. 4).